comparemela.com

Latest Breaking News On - Johnson fistel - Page 16 : comparemela.com

RILY ALERT: Johnson Fistel Encourages Investors to Inquire

The Securities and Exchange Commission is investigating B. Riley s dealings..

United statesSan diegoNew yorkFrankj johnsonJim bakerJohnson fistelJames bakerExchange commissionNomura holdingsInvestor relationsB rileyLass action

DADA NEWS: Johnson Fistel Encourages Dada Nexus Investors

SAN DIEGO, Jan. 19, 2024 (GLOBE NEWSWIRE) Johnson Fistel, LLP notifies investors of Dada Nexus Limited (NASDAQ: DADA) that a securities class action.

United statesNew yorkSan diegoFrankj johnsonJames bakerJohnson fistelDada nexus limitedInvestor relationsDada nexusClass periodLass action

MVST NEWS: Johnson Fistel Encourages Microvast Investors to Seek Counsel Before Lead Plaintiff

SAN DIEGO, Jan. 19, 2024 (GLOBE NEWSWIRE) Johnson Fistel, LLP announces that investors who incurred losses in Microvast Holdings, Inc. ("Microvast") (NASDAQ: MVST) that a securities class action lawsuit

United statesSan diegoNew yorkFrankj johnsonJohnson fistelJames bakerMicrovast holdings incMicrovast holdingsClass periodInvestor relations

Investigation Alert Apellis Pharmaceuticals, KeyCorp, ACI

SAN DIEGO, Jan. 16, 2024 (GLOBE NEWSWIRE) Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) Johnson Fistel, LLP is investigating potential claims.

United statesNew yorkSan diegoJames bakerJohnson fistelFrankj johnsonDigital corporationApellis pharmaceuticals incWorldwide incConsumer financial protection bureauElectronic fund transferAmerican society of retina specialistsApellis pharmaceuticalsAmerican societyRetina specialistsElectronic fund transfer act

SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Sale

SAN DIEGO, Jan. 16, 2024 (GLOBE NEWSWIRE) Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members.

United statesNew yorkSan diegoFrankj johnsonJim bakerJohnson fistelJames bakerCompany to synopsysAnsys incInvestor relationsNss newsLass action

vimarsana © 2020. All Rights Reserved.